Good point. You would think only a matter of time until the market catches wind. A biotech company with revenue scale, an actual commercial presence in the holy grail of the US, and with profitability forecast within the next 3-5 years. This is the same market that values IMU at 2.7b (not diluted) without a single cent of product sold.
IPO - Pacific Edge Limited - 23 September 2021 #, page-13
Add PEB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
-0.005(3.85%) |
Mkt cap ! $101.4M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 12.5¢ | $999 | 7.994K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 4224 | 1 |
View Market Depth
| Last trade - 10.19am 15/11/2024 (20 minute delay) ? |
| PEB (ASX) Chart |